Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of Epcoritamab in Relapsed and Refractory Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab
ClinicalTrials.gov study NCT06931652. IPD Sharing: NO. Countries: 1. Publications: 5.
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressiv
ClinicalTrials.gov study NCT01840566. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
ClinicalTrials.gov study NCT00466531. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
ClinicalTrials.gov study NCT03864419. IPD Sharing: NO. Countries: 1. Publications: 1.
Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
ClinicalTrials.gov study NCT04670029. IPD Sharing: NO. Countries: 1. Publications: 1.
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT00144755. IPD Sharing: Not stated. Countries: 3. Publications: 7.
B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
ClinicalTrials.gov study NCT02376335. IPD Sharing: Not stated. Countries: 1. Publications: 1.
R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B
ClinicalTrials.gov study NCT01852435. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma
ClinicalTrials.gov study NCT00138086. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research
ClinicalTrials.gov study NCT05747157. IPD Sharing: NO. Countries: 1. Publications: 1.
Correlation Between Vitamin D and B Regulatory Cell in Pregnancy
ClinicalTrials.gov study NCT04105881. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
ClinicalTrials.gov study NCT07319676. IPD Sharing: NO. Countries: 0. Publications: 18.
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
ClinicalTrials.gov study NCT06867991. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas
ClinicalTrials.gov study NCT01799083. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia
ClinicalTrials.gov study NCT02968472. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04799275. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT02776813. IPD Sharing: NO. Countries: 1. Publications: 1.
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
ClinicalTrials.gov study NCT00944567. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
ClinicalTrials.gov study NCT01284192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies
ClinicalTrials.gov study NCT02006485. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.